Gaut D, Mead M. Measurable residual disease in hematopoietic stem cell transplantation-eligible patients with acute myeloid leukemia: clinical significance and promising therapeutic strategies. Leuk Lymphoma 2020 Nov 2:1-24. doi: 10.1080/10428194.2020.1827251.
PMID: 33138674